Cheap medicine on the edge of Cliff: 70% doctors have been in short supply

Source: clove headline in April 20, 2016, in recent years, whether it's actinomycin D, ACTH, eumetronidazole and thiabendazole, the news of the shortage of cheap drugs often appears in our lives After the low-cost drugs have been announced, we can't help but ask, what are the medicines in short supply? The clove survey conducted an online survey on the shortage of cheap drugs, involving 8670 doctors with clinical prescription rights to see their situation What are the shortage of cheap drugs? A total of 77% (6693) of clinicians have experienced a shortage of cheap drugs when prescribing, of which 48% (4150) have fresh memories of the shortage So what cheap drugs are missing from their prescriptions? According to the statistics of doctors' shortage, the top 20 drugs are as shown in the following figure: Note: according to the summary statistics of the survey doctors' shortage, according to the frequency of drug shortage, they are ranked from more to less, and the distribution statistics of the shortage drugs in the following regions / departments are the same Due to the complexity of economic development and disease incidence in different parts of the country, there are some differences in the drugs that doctors encounter when prescribing Due to the different diseases treated in different departments, the shortage of cheap drugs encountered in the work is not the same Note: due to the small number of samples in other departments, no statistics were made In recent years, some irreplaceable cheap drugs are in short supply frequently, and its clinical significance is gradually highlighted In fact, the reason for the drug shortage is not so simple It can be subdivided into management drug shortage, policy drug shortage and market drug shortage Management drug shortage refers to the temporary shortage caused by the failure of relevant departments to purchase certain drugs or the untimely purchase; policy drug shortage refers to the shortage caused by the restriction of relevant drug system; market drug shortage includes the drugs that have not been developed, have been discontinued, and have insufficient production According to the results of the survey, the lack of drugs in the market is the main reason doctors think the shortage of cheap drugs A total of 53% of doctors (4582 people) believe that the shortage of drugs encountered is due to the lack of production in the market, and the low price and profit lead to the tendency of enterprises to produce less of these drugs Secondly, 30% of doctors (2562 people) think that the lack of bidding for drugs by the management department is also a problem of drug shortage Where is the future of cheap drugs in short supply? At present, according to the results of some cheap drugs retrieved from the insight database of DXY, it is shown that: drugs whose approval number has been cancelled: corticotropin for injection, bleomycin hydrochloride for injection, dapsone tablets, cyclophosphamide tablets, propafenone hydrochloride capsules, glimepiride capsules, coenzyme Q10 soft capsules, etc; The manufacturers have few drugs: Cediland, protamine sulfate injection, trypsin for injection, actinomycin D for injection, probenecid tablets, propafenone hydrochloride injection, cyclophosphamide for injection, haloperidol tablets, methimazole tablets, ketamine hydrochloride injection, human albumin, compound vitamin B Tablets, haloperidol, bromopyrimidine, ergometrine, etc In the face of many well-known drugs, the public needs to know when to ensure that more drug supplies do not light up the red light, so that problems that can be solved no longer become an additional burden for people's disease diagnosis and treatment Since 2014, the government has issued a series of policies to reduce the occurrence of similar drug interruption As a multi-party problem, it is urgent to establish an effective multi-party communication mechanism among the government, hospitals and enterprises, and through real-time monitoring of the production and circulation of special guaranteed drugs, to ultimately ensure that drugs provide comprehensive health protection for the majority of patients in the normal market Where is the way for the future shortage of cheap drugs? Let's wait and see.